0000899243-21-004246.txt : 20210202
0000899243-21-004246.hdr.sgml : 20210202
20210202181758
ACCESSION NUMBER: 0000899243-21-004246
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210202
DATE AS OF CHANGE: 20210202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Katz Richard D
CENTRAL INDEX KEY: 0001293577
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38268
FILM NUMBER: 21583052
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allena Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001624658
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 452729920
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE NEWTON EXECUTIVE PARK
STREET 2: SUITE 202
CITY: NEWTON
STATE: MA
ZIP: 02462
BUSINESS PHONE: 617-467-4577
MAIL ADDRESS:
STREET 1: ONE NEWTON EXECUTIVE PARK
STREET 2: SUITE 202
CITY: NEWTON
STATE: MA
ZIP: 02462
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-01
0
0001624658
Allena Pharmaceuticals, Inc.
ALNA
0001293577
Katz Richard D
C/O ALLENA PHARMACEUTICALS, INC.
ONE NEWTON EXECUTIVE PARK, SUITE 202
NEWTON
MA
02459
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
1.67
2021-02-01
4
A
0
400000
0.00
A
2031-02-01
Common Stock
400000
400000
D
25% shall vest on 2/1/2022 and the remaining 75% shall vest in equal monthly installments over the following thirty-six (36) months.
/s/ Kevin Brennan, attorney-in-fact
2021-02-02